Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Zacks.com on MSN
57m
NVO's Rybelsus Meets Primary Goal in MACE Study for Diabetes Patients
A late-stage study shows that Novo Nordisk's oral semaglutide, Rybelsus, cuts the risk of MACE by 14% in T2D patients ...
47m
Oxford Medical Products touts positive safety data for ‘mechanical’ weight loss pill
The company is eyeing a pivotal trial for its dual-polymer hydrogel stomach implant following promising first-in-human trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Arrested in trafficking case
Sued by Murdoch’s firms
Crew ID’d in WA jet crash
Splits with NY magazine
Chicago named 'rattiest city'
AR marijuana votes blocked
1st trans lawyer at SCOTUS
Arizona official pleads guilty
Copyright infringement suit
Blinken arrives in Israel
Right whale population rises
AU, US $4.7B missile deal
Washington state shooting
Infant mortality increased
Extends student loan pause
Meteorite aided early life?
Tests facial recognition tech
Target to cut prices
Overseas ballot suits denied
$400M aid package for UKR
Fuel pump concern recall
Probing leak of US intel
PA political threat case
Peru ex-president sentenced
China holds live-fire drills
US data protection move
FTC bans fake reviews
Union opts out of CBA
SK mulls arms for Ukraine
Raises US growth forecast
Related topics
Rybelsus
Diabetes mellitus type 2
Feedback